Modafinil, a wakefulness-promoting agent primarily used to deal with narcolepsy and other sleep disorders, has garnered vital consideration in recent times for its potential off-label uses, including cognitive enhancement and fatigue reduction. This observational analysis article aims to discover the availability of modafinil in the UK, the legal framework governing
